Eden Research plc, a company focused on sustainable biopesticides and plastic-free formulation technology, has announced a change in its Nominated Adviser and Broker. Following the completion of a merger between Cavendish Securities plc and Cavendish Financial plc, the company has switched from Cavendish Securities plc to Cavendish Capital Markets Limited. Eden Research develops and supplies biopesticide products and natural microencapsulation technologies to the global crop protection, animal health, and consumer products industries. Its products are formulated with terpene active ingredients based on natural plant defense metabolites. The company currently has two products on the market: Mevalone, a foliar biofungicide, and Cedroz, a bionematicide. Eden's Sustaine encapsulation technology is used to enhance the performance and ease-of-use of natural and synthetic compounds. The company was admitted to trading on AIM in 2012 and derives 100% of its total annual revenues from sustainable products and services.